U.S. Tobacco Stock News

Health Catalyst dropped about 25% to US$1.73 after its latest report, even though the headline numbers were not a collapse story. Q2 revenue landed at US$70.5 million and adjusted EBITDA came in at US$9.9 million, with adjusted EPS at US$0.04. The real jolt came from what happens next. The sale of the higher margin Vitalware unit, the shift to the Ignite platform and fresh guidance all reshape the earnings path from here. Investors may appreciate the recurring software revenue at Health...

In early August 2026, Zevra Therapeutics reported Q2 2026 results showing higher sales of US$39.66 million alongside lower net income of US$8.75 million compared with the prior year, while also highlighting strong US uptake of its Niemann-Pick disease type C therapy MIPLYFFA (arimoclomol). A separate publication of four-year, real-world data on arimoclomol in a broad Niemann-Pick disease type C population, including adults, adds clinically rich evidence that extends beyond prior pivotal...

Roper Technologies (NasdaqGS:ROP) subsidiary Illumia has appointed Eric Schuster as Chief Product Officer. Schuster brings extensive AI and enterprise software leadership experience from senior roles at ADP and Ceridian/Dayforce. The appointment is expected to shape Illumia's product roadmap, with a focus on client-centric solutions and practical AI use cases. For investors watching how AI and vertical SaaS shape long term software portfolios, it can be useful to look at a wider group of...

Las Vegas Sands stock has fallen 29.8% year to date, yet current checks suggest the shares may now sit close to their intrinsic value rather than being clearly cheap or expensive. Year to date the share price is down 29.8%, which puts recent sentiment under pressure and makes today's valuation levels especially important for new money going into Las Vegas Sands. Recent commentary around Macau and Singapore softness can weigh on growth expectations, while continued strength in domestic gaming...

In late July 2026, Healthcare Realty Trust filed shelf registrations covering up to US$775.08 million of securities, reported a second-quarter 2026 net loss of US$43.51 million on US$281.85 million in revenue, affirmed a US$0.24 per-share dividend, and updated full-year 2026 guidance to a loss per share between US$0.15 and US$0.11. Alongside these filings and results, the company kept its dividend intact while having completed US$99.88 million of prior share repurchases, underscoring a...

Roku stock inched up about 2% after earnings, which might look like a routine move for a company often framed as either a streaming winner in waiting or an overhyped advertising platform. The headline is less subtle. Roku just posted roughly US$1.11 in basic earnings per share on quarterly revenue of about US$1.35b, building on a trailing 12 month profit profile that now shows more than US$355m in earnings from continuing operations. The market reaction so far feels restrained compared with...

On 4 August 2026, Westinghouse Electric Company announced a series of agreements with Amentum to support its APX nuclear technology platform, including AP1000 fleet deployment, AP300 small modular reactor development and licensing, and joint work on delivering 1‑gigawatt reactors at scale. This collaboration deepens Amentum’s role across the nuclear project lifecycle, aligning its engineering and regulatory expertise with Westinghouse’s APX platform to pursue repeatable, fleet‑based reactor...

Sarepta Therapeutics (NasdaqGS:SRPT) appointed Michael Severino, M.D., as Chief Executive Officer and member of the Board of Directors. Severino joins Sarepta Therapeutics after senior leadership and research roles at Tessera Therapeutics, Flagship Pioneering, AbbVie, Amgen, and Merck. The leadership change places an experienced physician executive at the top of the company at a time when investors are watching for potential shifts in focus and execution. Consider reviewing other companies...

MDU Resources Group stock barely flinched after earnings, slipping about 1% to US$20.55, yet the quarter itself gave investors more to work with than that muted move suggests. For a regulated utility and pipeline operator, the headline was simple. Earnings per share in Q2 landed at about US$0.09, and management held firm on full year EPS guidance of US$0.93 to US$1.00. The stock came into the release with a trailing P/E around 22x, above both peers and the broader gas utilities group. That...

Zebra Technologies stock has climbed 51.6% year to date, yet the valuation checks and intrinsic value estimate are sending a more measured message, with the Discounted Cash Flow (DCF) view pointing to upside while market multiples suggest pricing that is closer to fair. The 51.6% year to date gain highlights how quickly expectations have shifted for Zebra Technologies, which puts extra focus on whether the current price still leaves room for long term value. Stronger recent revenue trends...

Fresh US tariffs tied to alleged forced labor in China are reshaping global supply chains and putting a spotlight on companies that make more at home. This creates potential openings and risks as money shifts toward U.S. based manufacturing strength. This article walks through three U.S. domestic manufacturing screener stocks that are closely exposed to this news and explains what the headlines could mean for your watchlist today. The three stocks in focus below are just a starting sample,...

Earlier this week, Prologis, Inc. completed a follow-on equity offering of 15,000,000 common shares, raising about US$2.10 billion at US$139.85 per share with a US$1.10 discount. This capital raise follows Prologis’ upbeat Q2 FY2026 update, where the company lifted full-year guidance for Core FFO, net earnings, occupancy and cash same-store NOI. Next, we’ll consider how Prologis’ large equity raise shapes its investment narrative, especially around funding logistics expansion and data center...

UnitedHealth Group stock has delivered a strong 66.6% gain over the past year, yet its valuation checks and current pricing still leave room for debate about how much upside is already reflected in the share price. Over the last 1 year, the stock is up 66.6%, which puts recent buyers in a comfortable position but raises the bar for future returns to justify this move. UnitedHealth Group's diversified health insurance and services model can support expectations for steady cash generation,...

Cooling US consumer inflation expectations and softer wage growth have shifted attention back to cash generation and valuation discipline. When price pressure is less of the story, the gap between what a stock earns in cash and what the market pays for it can stand out more clearly. This article highlights 3 stocks from the Undervalued Stocks Based On Cash Flows screener that currently screen as undervalued on cash flow. The three stocks below are just a starting sample. The full screen...

Aemetis stock had already been under pressure over the past quarter, then popped 5.5% to $1.72 after the Q2 release. That one-day relief rally sits on top of a still heavy loss over 90 days, which indicates traders are reacting to a single message. The headline is clear. Revenue reached $62.7m in Q2 and the company reported positive operating income of $5.8m while the net loss narrowed to $9.4m. The emotional tension is between interest in that margin turnaround and ongoing concern about...

Optimum Communications stock came into this earnings print beaten up, down about 43% over the past month and another 4% today to roughly $0.77. Yet the headline from the quarter is not the share price slide; it is a telecom business squeezing more profit out of each dollar of revenue even while the top line drifts lower. Gross margin reached a record 71% and adjusted earnings before interest, tax, depreciation and amortization margin widened to 38.8%. For investors with a longer horizon, that...

Avient stock jumped 7.1% to US$45.69 into the close, capping a strong run that already had the shares up around 28% over the past month. The move is all about one thing: profitability. Adjusted earnings per share of US$0.96 topped expectations and rode on a record adjusted EBITDA margin of 18.3% in the quarter. For a specialty materials company that depends on margin quality and cash generation, that is the real story. The short-term price pop is loud. The multi-year question is whether this...

Inflation is back in the spotlight as investors brace for the July CPI report, fresh earnings and an uncertain Federal Reserve path. With markets swinging between optimism over falling oil prices and concern about what comes next for rates, reliable dividend income can feel more valuable than ever. This article looks at three large dividend stocks from our inflation resilient screener that appear closely tied to these macro shocks. The three stocks that follow are only a starting sample,...

The Baldwin Insurance Group, Inc. reported its second-quarter 2026 results, with revenue rising to US$492.94 million while swinging to a net loss of US$39.00 million, and also issued third-quarter revenue guidance of US$485 million to US$495 million. The combination of higher revenue yet wider losses, alongside fresh guidance for the coming quarter, gives investors new information on how growth is balancing against profitability and cost pressures. Next, we will examine how Baldwin’s shift...

DXP Enterprises stock has produced very strong multi year returns, and after the latest move the Discounted Cash Flow (DCF) intrinsic value estimate and the earnings multiples both suggest the shares now look closer to fairly valued than clearly cheap. Over the past 5 years, DXP Enterprises has delivered a gain of more than 7x, which puts extra focus on whether the current price still leaves much room for error. The recently announced acquisition of Mequipco Ltd. may support growth...

Etsy stock has climbed sharply over the past year, yet the valuation signals are split, with the Discounted Cash Flow (DCF) intrinsic value estimate pointing to upside while earnings-based multiples lean in the other direction. Over the past 5 years, Etsy shares have declined 55.5%, which means recent gains still sit against a weak longer-term return profile. Recent analyst upgrades and a focus on core marketplace growth can support higher cash flow expectations, while competition from large...

LKQ (LKQ) reported second quarter 2026 results with lower earnings and revised full year guidance on July 30, 2026. The update highlighted softer European trends and ongoing recovery work following an ERP rollout in Germany. See our latest analysis for LKQ. LKQ shares have been under pressure this year, with the year to date share price return down 17.22% despite a 10.73% 7 day share price rebound after the earnings. The 3 year total shareholder return is down 49.05%, pointing to fading...

Bilibili stock sits in an awkward spot for valuation focused investors. The Discounted Cash Flow (DCF) intrinsic value estimate points to sizeable upside relative to the current share price, while market based multiples suggest the stock is not cheap, and the broader checks land somewhere in the middle. Over the past 5 years, Bilibili shareholders have seen the share price decline about 74.7%, which sets a low base for any valuation case today. The long term equity story still turns on...

When cloud and AI software stocks like Atlassian and Twilio move sharply on earnings, it can reset expectations across the whole sector in a single session. That kind of shake up can create opportunities for investors who understand which businesses are riding the same demand trends and which are struggling to keep up. This article unpacks 3 stocks exposed to the latest AI driven news and what their setups might mean for your portfolio. The stocks covered below are just a starting sample, and...